/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.07%
Natural Gas
-0.42%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.27%
VIX
N/A
Economic Calendar
EUR/USD
+0.07%
Natural Gas
-0.42%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.27%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
The Week Ahead: Global Currencies Brace for Impactful Economic Data Releases
about 10 hours ago
Five Things to Know Crypto This Week: Gensler Grilling, Crypto ETFs, and Big Brother
about 17 hours ago
Michigan Consumer Sentiment Exceeds Analyst Expectations
2 days ago
Eurostat Reports: Eurozone Faces Sharp Inflation Decline in September
2 days ago
UK GDP Report Offered Relief, with the UK Economy Growing by 0.2% in Q2
2 days ago
GDP Growth Rate Meets Analyst Estimates, Traders Stay Focused On Fed Policy Outlook
3 days ago
Market Insight: Week Ending 6 October
about 9 hours ago
EUR/USD Forecast: 11-Week Losing Streak; A Services Sector Spark Ahead?
about 9 hours ago
Crypto News: Coinbase CEO Armstrong Talks Legislation, SEC, and Global Crypto Pre-SBF Trial
about 11 hours ago
XRP News: SEC’s Appeal Tensions Rise, Ripple and Coinbase Cases Intersect
about 14 hours ago
Natural Gas Prices Forecast: Mixed Signals Amid Fluctuating Supply/Demand Factors
about 17 hours ago
Silver Prices Forecast: Why a Strong Dollar and Fed Policies Could Undermine XAG/USD
about 9 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
BDSwiss Academy
ad
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
LLY
profile
Lilly(Eli) & Co
Follow
LLY
(
NYSE
)
Closed
537.46
-6.99 (-1.28%)
in
:
usd
•
As of: Sep 29, 2023 15:59
UTC -4
After Market
:
537.25
-0.21 (-0.04%)
Open
545.53
High
545.53
Low
532.23
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Dividends
About
Lilly(Eli) & Co
CEO
David A. Ricks
Headquarters
lilly corporate center
indianapolis, in 46285, united states
Auditor
Ernst & Young LLP
Employees
39,000
Share Holders
19,868
Website
www.lilly.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure on its U.S. diabetes franchise. Its pharmaceutical product categories are neuroscience, diabetes, oncology, immunology and others. Over the past few years, Lilly has been actively seeking acquisitions and in-licensing deals to boost its product portfolio and pipeline. The purchase of ImClone Systems brought with it cancer compound, Erbitux. The acquisition of ICOS Corporation gave Lilly full control over erectile dysfunction drug, Cialis. Its other acquisitions include Hypnion, Inc., CoLucid Pharmaceuticals added Reyvow for acute migraine, Loxo Oncology and Dermira. Lilly has collaboration agreements with several companies including Incyte, Boehringer Ingelheim and Innovent Biologics among others.
Lilly(Eli) & Co
Statistics
Valuation Measures
Market Capitalization
2
510.21B
Enterprise Value
526.33B
Enterprise Value/EBITDA
(ttm)
61.21
Price to Earnings Ratio
(ttm)
68.86
Price to Book
(mrq)
45.73
Price to Sales
(ttm)
17.28
Price to Cash
(ytd)
58.60
Profitability
Gross Margin
(ttm)
77.73%
Operating Margin
(ttm)
23.89%
Profit Margin
(ttm)
22.00%
Return on Equity
(ttm)
65.00%
Return on Invested Capital
(ttm)
24.04%
Return on Assets
(ttm)
13.76%
Income Statement
Revenue
(ttm)
29.52B
Revenue Per Share
(ttm)
31.09
Gross Profit
(ttm)
22.95B
EBITDA
(ttm)
3
8.60B
Net Income Avi to Common
(ttm)
6.50B
Diluted EPS
(ttm)
7.19
Share Statistics
Beta (5Y Monthly)
0.32
52-Week Change
68.95%
S&P500 52-Week Change
16.57%
S&P500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding
1
949.30M
Dividend Yield
0.84%
Float
4
948.06M
%
Held by Insiders
0.13%
%
Held by Institutions
81.38%
Balance Sheet
Total Cash
(mrq)
2.83B
Total Cash Per Share
(mrq)
2.98
Total Debt
(mrq)
18.82B
Total Debt/Equity
(mrq)
168.80%
Current Ratio
(mrq)
1.13%
Quick Ratio
(mrq)
0.87%
Book Value Per Share
(mrq)
11.74
Cash Flow
Operating Cash Flow Per Share
(ytd)
2.62
Free Cash Flow
(ytd)
955.80M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker